BIO Taps Big Pharma Execs for Federal Comparative Effectiveness Research Board Nominations
This article was originally published in The Pink Sheet Daily
Executive Summary
Four of BIO's six nominations are also PhRMA's nominations for the Patient-Centered Outcomes Research Institute board of governors.